Evolution of Fatigue in Patients With Inflammatory Bowel Disease
Aperçu de l'étude
Statut
Description détaillée
Fatigue is a common symptom in inflammatory bowel disease and persists despite clinical remission. Fatigue in patients with chronic diseases can be objectified by the FACIT-F scale.
Recent publications have tried to assess the prevalence and factors related to fatigue in patients with IBD.
In 2017 one study evaluated the prevalence and predictive factors of fatigue in out-patients with inflammatory bowel disease. Fatigue was associated with depression, low quality of life and female sex. No association was found with micronutrients or levels of interleukins.
As there are no effective treatments for fatigue in IBD, another study, recently published a study evaluating the role of electroacupuncture in 54 patients with quiescent IBD and fatigue, observing that both electroacupuncture and sham acupuncture improved fatigue compared to the control group.
The aim of this study is to evaluate the evolution and possible factors associated with the persistence of fatigue in patients with quiescent IBD and fatigue included in the two previous studies.
Patients with inflammatory bowel disease and fatigue (FACIT-F score < 40) included in these two previous studies who agree to participate will fill in questionnaires to assess fatigue, anxiety, depression and quality of life in inflammatory bowel disease. Moreover, the relationship of other biological factors with IBD-related fatigue will be determined.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Diana Horta
- Numéro de téléphone: 93 745 84 54
- E-mail: diana.horta.s@gmail.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Patients with inflammatory bowel disease and fatigue (defined as a FACIT-F score <40 points) previously documented in our two previous studies.
- Written informed consent after receiving clear and objective information about the purpose and characteristics of the study.
- Ability to understand the questionnaires.
Exclusion Criteria:
- Associated tumor disease.
- Pregnancy or breastfeeding.
- Anemia (hemoglobin <12g/dl in women and 14g/dl in men)
- Any concomitant illness that may justify the presence of fatigue.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Patients with Inflammatory Bowel Disease and fatigue
Patients with Inflammatory Bowel Disease and fatigue that participated in the two studies (1,2).
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Evaluate the evolution of fatigue in patients with Inflammatory Bowel Disease at 3 years
Délai: three years
|
Assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F scale).
This questionnaire, previously validated in Spanish and for IBD patients, comprises 40 items divided into five subscales: Physical wellbeing (PWB), Social/family wellbeing (SWB), Emotional wellbeing (EWB), Functional Wellbeing (FWB), and Fatigue subscale.
The first four subscales (27 items) evaluate general features of chronic illness, and the 13 items of the Fatigue subscale specifically focus on fatigue.
Each item has five possible answers, from 0 (very fatigued) to 4 (not at all fatigued).
The score of each subscale is the sum of the coded values of its items.
|
three years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Assess the biological factors associated with the persistence of fatigue
Délai: three years
|
Assessed by a blood test including micronutrients (vitamin B12, ferritin and vitamin D).
|
three years
|
|
Assess the psychological factors associated with the persistence of fatigue
Délai: three years
|
Assessed by the Beck Depression Inventory (BDI) questionnaire.
The Spanish validated 21-item version of the BDI will be used to analyze depression.
This self-administered questionnaire evaluates the clinical features of melancholy and intrusive thoughts present in depression.
Each item has a different number of options (from 4 to 8), which then have to be converted into four possible values (0, 1, 2, or 3).
Higher BDI scores indicate a higher grade of depression.
|
three years
|
|
Assess the psychological factors associated with the persistence of fatigue
Délai: three years
|
Assessed by Quality of life in inflammatory bowel disease questionnaire (IBDQ-9).
he IBDQ-9 consists of nine items assessing different aspects of life in IBD patients.
Each item has seven different possible answers, scoring from 1 (poorest) to 7 (best).
The straight summation of all nine items provides a direct score, which is then transformed into a final score.
Higher scores correspond to a better quality of life.
|
three years
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Diana Horta, Parc Tauli Hospital. Sabadell , Barcelona, Spain, 08208
Publications et liens utiles
Publications générales
- Villoria A, Garcia V, Dosal A, Moreno L, Montserrat A, Figuerola A, Horta D, Calvet X, Ramirez-Lazaro MJ. Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors. PLoS One. 2017 Jul 27;12(7):e0181435. doi: 10.1371/journal.pone.0181435. eCollection 2017.
- Horta D, Lira A, Sanchez-Lloansi M, Villoria A, Teggiachi M, Garcia-Rojo D, Garcia-Molina S, Figuerola A, Esteve M, Calvet X. A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Feb 11;26(3):484-492. doi: 10.1093/ibd/izz091.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HMT3
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .